Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Induction of Regulatory t Cells by Low Dose IL2 in Autoimmune and Inflammatory Diseases: a Transnosographic Approach

NCT01988506 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.

NCT NCT01988506
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01988506 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Induction of Regulatory t Cells by Low Dose IL2 in Autoimmune and Inflammatory Diseases: a Transnosographic Approach
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Phase
Phase 2
Overall status
Completed
Start date
January 6, 2014
Completion date
April 1, 2021
Enrollment
81 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

ankylosing spondylitis, autoimmune hepatitis, behcet's disease, crohn's disease, gougerot-sjögren, idiopathic thrombocytopenic purpura, psoriasis, rheumatoid arthritis, sclerosing cholangitis, systemic lupus erythematosus, systemic sclerosis, takayasu's disease, ulcerative colitis, wegener's granulomatosis